Risk Disclosure: This website's content is not investment advice and offers no trading guidance or related services. Per regulations from the PBOC and other authorities, users must be aware of virtual currency risks. Contact us / [email protected] ICP License: 琼ICP备2022009338号
TechFlow news, September 3 — According to Investing.com, biotech company Artelo Biosciences (NASDAQ: ARTL) announced a private placement financing plan of $9.475 million, which will launch a reserve strategy based on Solana. Currently, Artelo Biosciences has a market capitalization of $11.4 million and a stock price of $8.76.
According to Investing.com, biotech company Artelo Biosciences (NASDAQ: ARTL) has announced a $9.475 million private placement financing plan that will launch a reserve strategy based on Solana. Currently, Artelo Biosciences has a market cap of $11.4 million and a stock price of $8.76.
Navigating Web3 tides with focused insights
